S&P 500   3,116.51 (+0.12%)
DOW   27,673.05 (+0.08%)
QQQ   202.71 (+0.14%)
AAPL   265.46 (+1.42%)
FB   199.29 (+0.29%)
MSFT   150.07 (+0.15%)
GOOGL   1,324.84 (+0.45%)
AMZN   1,747.05 (-0.77%)
CGC   18.49 (+0.60%)
NVDA   208.49 (-0.44%)
MU   46.54 (+0.52%)
BABA   199.97 (+3.22%)
GE   10.80 (-1.01%)
TSLA   331.35 (-0.50%)
T   38.18 (+0.18%)
AMD   39.76 (+0.18%)
ACB   2.43 (-2.41%)
F   8.91 (-0.45%)
NFLX   302.07 (-0.74%)
BAC   33.18 (+0.06%)
GILD   65.78 (-1.45%)
DIS   148.16 (-0.08%)
S&P 500   3,116.51 (+0.12%)
DOW   27,673.05 (+0.08%)
QQQ   202.71 (+0.14%)
AAPL   265.46 (+1.42%)
FB   199.29 (+0.29%)
MSFT   150.07 (+0.15%)
GOOGL   1,324.84 (+0.45%)
AMZN   1,747.05 (-0.77%)
CGC   18.49 (+0.60%)
NVDA   208.49 (-0.44%)
MU   46.54 (+0.52%)
BABA   199.97 (+3.22%)
GE   10.80 (-1.01%)
TSLA   331.35 (-0.50%)
T   38.18 (+0.18%)
AMD   39.76 (+0.18%)
ACB   2.43 (-2.41%)
F   8.91 (-0.45%)
NFLX   302.07 (-0.74%)
BAC   33.18 (+0.06%)
GILD   65.78 (-1.45%)
DIS   148.16 (-0.08%)
S&P 500   3,116.51 (+0.12%)
DOW   27,673.05 (+0.08%)
QQQ   202.71 (+0.14%)
AAPL   265.46 (+1.42%)
FB   199.29 (+0.29%)
MSFT   150.07 (+0.15%)
GOOGL   1,324.84 (+0.45%)
AMZN   1,747.05 (-0.77%)
CGC   18.49 (+0.60%)
NVDA   208.49 (-0.44%)
MU   46.54 (+0.52%)
BABA   199.97 (+3.22%)
GE   10.80 (-1.01%)
TSLA   331.35 (-0.50%)
T   38.18 (+0.18%)
AMD   39.76 (+0.18%)
ACB   2.43 (-2.41%)
F   8.91 (-0.45%)
NFLX   302.07 (-0.74%)
BAC   33.18 (+0.06%)
GILD   65.78 (-1.45%)
DIS   148.16 (-0.08%)
S&P 500   3,116.51 (+0.12%)
DOW   27,673.05 (+0.08%)
QQQ   202.71 (+0.14%)
AAPL   265.46 (+1.42%)
FB   199.29 (+0.29%)
MSFT   150.07 (+0.15%)
GOOGL   1,324.84 (+0.45%)
AMZN   1,747.05 (-0.77%)
CGC   18.49 (+0.60%)
NVDA   208.49 (-0.44%)
MU   46.54 (+0.52%)
BABA   199.97 (+3.22%)
GE   10.80 (-1.01%)
TSLA   331.35 (-0.50%)
T   38.18 (+0.18%)
AMD   39.76 (+0.18%)
ACB   2.43 (-2.41%)
F   8.91 (-0.45%)
NFLX   302.07 (-0.74%)
BAC   33.18 (+0.06%)
GILD   65.78 (-1.45%)
DIS   148.16 (-0.08%)
Log in

ASTELLAS PHARMA/ADR Price Target & Analyst Ratings (OTCMKTS:ALPMY)

$16.85
-0.23 (-1.35 %)
(As of 12/5/2019 02:55 PM ET)
Today's Range
$16.81
Now: $16.85
$17.04
50-Day Range
$15.20
MA: $16.57
$17.26
52-Week Range
$12.41
Now: $16.85
$17.33
Volume38,770 shs
Average Volume76,331 shs
Market Capitalization$31.83 billion
P/E Ratio16.20
Dividend Yield0.76%
Beta0.78

Analyst Ratings

ASTELLAS PHARMA/ADR (OTCMKTS:ALPMY) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
1 Wall Street analysts have issued ratings and price targets for ASTELLAS PHARMA/ADR in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldHoldHold
Consensus Rating Score: 3.002.001.501.67
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

ASTELLAS PHARMA/ADR (OTCMKTS:ALPMY) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

ASTELLAS PHARMA/ADR (OTCMKTS:ALPMY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
9/24/2019Jefferies Financial GroupInitiated CoverageBuy
11/5/2018JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
9/13/2018Deutsche BankDowngradeBuy ➝ Hold
6/8/2018Goldman Sachs GroupDowngradeBuy ➝ Neutral
(Data available from 12/5/2017 forward)
This page was last updated on 12/5/2019 by MarketBeat.com Staff

Featured Article: What is a conference call?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel